结构异常胎儿的产前外显子组测序分析:一项具有实践意义的多中心前瞻性队列研究
该多中心前瞻性队列研究(2018-2021年)纳入275例染色体微阵列分析(CMA)和核型分析阴性的结构异常胎儿,评估外显子组测序联合拷贝数变异(CNV)和单核苷酸变异(SNV)分析的诊断价值,总诊断率为29.45%(81/275),复发异常组最高(40.68%),并发现1.45%病例存在复合CNV/SNV组合。
要点
- ES-CNV/SNV分析将结构异常胎儿的诊断率提高至29.45%(81/275)。
- 复发异常组诊断率最高(40.68%,24/59),多系统组28.41%(25/88),单系统组25.00%(32/128)。
- 1.45%病例检出复合CNV/SNV组合,扩展了36个变异和5个基因的产前表型-基因型关联。
核心结论
- ES-CNV/SNV分析通过检测标准检测无法发现的复合CNV/SNV组合,提高了产前诊断精确性。
- 复发异常比散发性单系统或多系统异常显示出更大的诊断获益,凸显了该方法在高危病例中的效用。
- 本研究拓宽了产前表型谱并加深了对发育机制的理解。
研究设计与样本
- 多中心前瞻性队列研究,2018-2021年纳入275例结构异常胎儿。
- 胎儿分为三组:散发性单系统异常(n=128)、散发性多系统异常(n=88)、复发异常(n=59)。
- 采用基于家系三联的ES-CNV/SNV分析,识别SNV、CNV或复合杂合CNV/SNV组合。
主要发现
- ES-CNV/SNV分析将诊断率提高至29.45%(81/275), compared with 常规染色体分析联合CMA。
- 复发异常组诊断率最高(40.68%,24/59),多系统组为28.41%(25/88),单系统组为25.00%(32/128)。
- 1.45%的病例存在复合CNV/SNV组合。
- 本研究扩展了36个变异和5个基因的产前表型-基因型关联。
关键数值与推荐
- 复合杂合CNV/SNV组合定义为同一基因内两个不同致病变异(一个CNV和一个SNV)共存,导致双等位基因功能缺陷。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the diagnostic value of prenatal exome sequencing (ES) integrated with copy number variant (CNV) and single nucleotide variant (SNV) analysis (ES-CNV/SNV) in fetuses with structural anomalies following negative chromosomal microarray analysis (CMA) and karyotyping, and to delineate the practical challenges encountered during its clinical implementation in prenatal settings. METHODS: In this multicenter prospective cohort study (2018-2021), 275 fetuses with structural anomalies were categorized into three groups: sporadic single-system (n = 128), sporadic multisystem (n = 88), and recurrent anomalies (n = 59). Trio-based ES-CNV/SNV analysis was used to identify SNVs, CNVs, or compound heterozygous CNV/SNV combinations- the latter being defined as two distinct pathogenic variants (a CNV and an SNV) coexisting within the same gene, resulting in biallelic gene dysfunction, which is pivotal for autosomal recessive disorders. Incremental diagnostic yields across groups, the incidence of CNV/SNV combinations, and expanded prenatal phenotypic-genotypic correlations were analyzed. RESULTS: ES-CNV/SNV analysis improved the diagnostic yield to 29.45% (81/275) compared with conventional chromosome analysis combined with CMA in fetuses with malformations. The highest diagnostic yield was observed in the recurrent anomaly group (40.68%, 24/59), followed by the multisystem (28.41%, 25/88) and single-system anomaly groups (25.00%, 32/128). Notably, 1.45% of cases harbored compound CNV/SNV combinations, underscoring the diagnostic potential of ES-CNV/SNV in autosomal recessive disorders. In addition, this study expanded prenatal phenotypic-genotypic correlations for 36 variants and five genes. CONCLUSION: ES-CNV/SNV analysis enhances prenatal diagnostic precision by detecting compound CNV/SNV combinations that are undetectable by standard testing. Recurrent anomalies demonstrated a greater diagnostic benefit than sporadic single-system or multisystem anomalies, underscoring the utility of this method in high-risk cases. This study broadens the prenatal phenotypic spectrum and deepens our understanding of developmental mechanisms.
引用
- Jiang Y, Li H, Zhu X, et al. Prenatal Exome Sequencing Analysis in Fetuses With Structural Anomalies: A Multicenter Prospective Cohort Study With Practical Implications. Prenat Diagn. 2025. PMID: 41108211. doi:10.1002/pd.70006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。